To further and significantly extend these data, immunohistochemical analysis of TSPAN1 were performed in a cohort of 106 laryngeal and pharyngeal cancer patients, and correlated with clinical data and disease outcome (Table S7). The gene discussed is TSPAN1; the disease is pharynx cancer.